We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VIZO-PF DORZOLATIM (AFT Pharmaceuticals Pty Ltd)
Product name
VIZO-PF DORZOLATIM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
139 (255 working days)
Active ingredients
dorzolamide hydrochloride; timolol maleate
Registration type
New generic medicine
Indication
VIZO-PF DORZOLATIM (eye drop solution) is indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.